Euroapi S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EAPI.PA research report →
About the company
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
- CEO
- David Seignolle
- IPO
- 2022
- Employees
- 3,187
- HQ
- Paris, FR
Price Chart
- Market Cap
- $124.62M
- P/E
- -0.58
- P/S
- 0.15
- P/B
- 0.16
- EV/EBITDA
- 0.54
- Div Yield
- 0.00%
- Gross Margin
- 16.80%
- Op Margin
- -4.23%
- Net Margin
- -24.83%
- ROE
- -24.26%
- ROIC
- -3.40%
- Revenue
- $848.20M · -7.72%
- Net Income
- $-211,200,000 · -61.72%
- EPS
- $-2.23 · -61.59%
- Op Income
- $200.00K
- FCF YoY
- 215.44%
- 52W High
- $3.44
- 52W Low
- $1.22
- 50D MA
- $1.36
- 200D MA
- $2.17
- Beta
- 0.97
- Avg Volume
- 153.57K
Get TickerSpark's AI analysis on EAPI.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EAPI.PA coverage
Recent articles, reports, and earnings notes.
No research on EAPI.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EAPI.PA report →Similar companies
Peers in the same neighborhood.